Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.
Int J Pharm. 2013 Oct 15;455(1-2):259-66. doi: 10.1016/j.ijpharm.2013.07.022. Epub 2013 Jul 19.
This study developed a novel oral insulin formulation centered on microspheres consisting of a blend of biodegradable poly(ester amide) (PEA). In the formulation, L-lysine-/L-leucine-based PEA with pendant COOH groups (PEA-COOH) was used as a pH-responsive material for the protection of insulin from the harsh environmental conditions of the stomach. Arginine-based PEA (Arg-PEA) was introduced to improve the intestinal absorption of the drug. The influence of both the hydrophobicity of PEA-COOH and the content of Arg-PEA was investigated in detail on microsphere surface morphology, drug loading, and the in vitro release profile of insulin. The PEA-COOH/Arg-PEA blend microspheres protected the loaded insulin in simulated gastric fluid and released insulin in a fast and sustained manner in simulated intestinal fluid. The in vivo test demonstrated that the oral administration of insulin-loaded PEA blend microspheres could effectively suppress the blood glucose level in diabetic rats for 10h, and the oral bioavailability was improved to 5.89+1.84% in healthy rats. These results indicate that the PEA blend microspheres are promising vehicles for the oral delivery of insulin.
本研究开发了一种新型的以微球为中心的口服胰岛素制剂,该微球由可生物降解的聚酯酰胺(PEA)混合物组成。在该制剂中,使用赖氨酸/亮氨酸基 PEA(PEA-COOH)作为 pH 响应材料,以保护胰岛素免受胃内恶劣环境的影响。引入精氨酸基 PEA(Arg-PEA)以提高药物的肠道吸收。详细研究了 PEA-COOH 的疏水性和 Arg-PEA 的含量对微球表面形态、药物载药量和胰岛素体外释放行为的影响。PEA-COOH/Arg-PEA 共混微球在模拟胃液中保护负载的胰岛素,并在模拟肠液中快速持续释放胰岛素。体内试验表明,口服载胰岛素的 PEA 共混微球可有效抑制糖尿病大鼠 10 小时的血糖水平,口服生物利用度在健康大鼠中提高至 5.89+1.84%。这些结果表明,PEA 共混微球是胰岛素口服递送的有前途的载体。